Parabilis Medicines (PBLS) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 17 69 sessions, June 10, 2026 to September 17, 2026
- Largest daily move
- +10.8% close of September 17, 2026
Company Description
Parabilis Medicines (NASDAQ: PBLS) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $4.9B.
PBLS has gained 9.8% over the past month. The last closing price was $40.88.
This page collects what Stock Titan holds for PBLS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Parabilis Medicines (PBLS) closed at $40.88 on September 17, 2026. Over the past month, the price has gained 9.8%.
PBLS Metrics & Rankings
Price returns through September 17, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Parabilis Medicines has 5 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. Key topics include management, earnings, IPO, offering. View all PBLS news →
SEC Filings
Parabilis Medicines has filed 10 recent SEC filings, including 4 Form 8-K, 2 Form 4, 2 Form SCHEDULE 13G, 1 Form 3. The most recent filing was submitted on September 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PBLS SEC filings →
Insider Radar
Insider buying activity at Parabilis Medicines over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Parabilis Medicines (PBLS) currently stands at 5.5 million shares, up 5.0% from the previous reporting period, representing 5.2% of the float. Since June 2026, short interest has increased by 394.2%. With 14.2 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Parabilis Medicines (PBLS) currently stands at 14.2 days, down 9.8% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 967.7% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.3 to 15.7 days.
PBLS Company Profile & Sector Positioning
Parabilis Medicines (PBLS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.